Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study

Phase Ii ◽

Regional Differences ◽

Phase Ii Study ◽

Second Line ◽

Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma

Annals of Oncology ◽

10.1093/annonc/mdv388 ◽

2015 ◽

Vol 26 (12) ◽

pp. 2457-2463 ◽

Cited By ~ 43

Author(s):

Y.-K. Kang ◽

T. Yau ◽

J.-W. Park ◽

H.Y. Lim ◽

T.-Y. Lee ◽

...

Keyword(s):

Supportive Care ◽

Phase Ii ◽

Phase Ii Study ◽

Best Supportive Care ◽

Line Treatment ◽

Second Line ◽

A Multicenter Phase II Study of Second‐Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy

The Oncologist ◽

10.1634/theoncologist.2020-0143 ◽

2020 ◽

Vol 25 (9) ◽

Cited By ~ 1

Author(s):

Zhong‐Zhe Lin ◽

Bang‐Bin Chen ◽

Yi‐Ping Hung ◽

Po‐Hsiang Huang ◽

Ying‐Chun Shen ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

First Line ◽

Multicenter Phase

Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma

Oncology ◽

10.1159/000334439 ◽

2011 ◽

Vol 81 (5-6) ◽

pp. 281-290 ◽

Cited By ~ 47

Author(s):

Tatsuya Yamashita ◽

Kuniaki Arai ◽

Hajime Sunagozaka ◽

Teruyuki Ueda ◽

Takeshi Terashima ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Hepatic Arterial Infusion ◽

Arterial Infusion ◽

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800050982 ◽

1999 ◽

Vol 44 (4) ◽

pp. 307-311 ◽

Cited By ~ 34

Author(s):

Tony S. K. Mok ◽

Thomas W. T. Leung ◽

Shou-Dong Lee ◽

Yee Chao ◽

Anthony T. C. Chan ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Chinese Patients ◽

A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma

Liver Cancer ◽

10.1159/000486460 ◽

2018 ◽

Vol 7 (2) ◽

pp. 165-178 ◽

Cited By ~ 5

Author(s):

Chia-Jui Yen ◽

Tae-You Kim ◽

Yin-Hsun Feng ◽

Yee Chao ◽

Deng-Yn Lin ◽

...

Keyword(s):

Phase I ◽

Phase Ii ◽

Phase Ii Study ◽

Asian Patients ◽

5-fluorouracil arterial infusion + interferon therapy for highly advanced hepatocellular carcinoma: A multicenter, randomized, phase II study

Hepatology Research ◽

10.1111/j.1872-034x.2011.00905.x ◽

2011 ◽

Vol 42 (2) ◽

pp. 150-165 ◽

Cited By ~ 19

Author(s):

Morito Monden ◽

Masato Sakon ◽

Yuh Sakata ◽

Yoshitaka Ueda ◽

Etsuro Hashimura ◽

...

Keyword(s):

Phase Ii ◽

Interferon Therapy ◽

Phase Ii Study ◽

Arterial Infusion ◽

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

Oncotarget ◽

10.18632/oncotarget.11621 ◽

2016 ◽

Vol 7 (45) ◽

pp. 72622-72633 ◽

Cited By ~ 33

Author(s):

Lorenza Rimassa ◽

Giovanni Abbadessa ◽

Nicola Personeni ◽

Camillo Porta ◽

Ivan Borbath ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Circulating Biomarkers ◽

Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000099 ◽

2016 ◽

Vol 39 (6) ◽

pp. 609-613 ◽

Cited By ~ 13

Author(s):

Francis A.S. Lee ◽

Benny Chung-Ying Zee ◽

Foon Yiu Cheung ◽

Philip Kwong ◽

Chi Leung Chiang ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Inhibitor Of Apoptosis ◽

Faculty of 1000 evaluation for Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718021759.793480257 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Progesterone Receptor ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii ◽

Positive Breast Cancer

Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2892-7 ◽

2016 ◽

Vol 77 (2) ◽

pp. 243-250 ◽

Cited By ~ 7

Author(s):

Hiroaki Nagamatsu ◽

Shuji Sumie ◽

Takashi Niizeki ◽

Nobuyoshi Tajiri ◽

Hideki Iwamoto ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Hepatic Arterial Infusion ◽

Arterial Infusion ◽

Multicenter Phase